EMEA-003577-PIP01-24 - paediatric investigation plan
certepetide
PIPHuman
Key facts
- Active Substance
- certepetide
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Decision number
- P/0216/2024
- PIP number
- EMEA-003577-PIP01-24
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of pancreatic cancer
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Lisata Therapeutics Ireland Limited
E-mail: info@lisata.com
Tel: +1 9495352391- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date